Bethesda, Md., April 21, 2014 – The Parenteral Drug Association (PDA) announced today that it has confirmed the participation of four experts from the U.S. FDA in the upcoming 2014 PDA/FDA Pharmaceutical Supply Chain Conference,June 3-4, 2014, at the JW Marriott in Washington, DC.
The four U.S. FDA experts represent the Center for Drug Evaluation and Research (CDER) Office of Compliance Office of Drug Security, Integrity and Recalls (ODSIR):
- Thomas Christl, Office Director
- Connie Jung, PhD, Associate Director, Policy & Communication
- Mark Paxton, Regulatory Counsel
- Steven Wolfgang, Acting Associate Director, Risk Science, Intelligence And Prioritization
“PDA is pleased to once again provide industry representatives an opportunity to interact with representatives of the U.S. FDA at one of our regulatory meetings,” said PDA President Richard Johnson. “This will be the fifth time PDA and the U.S. FDA have cosponsored a conference or workshop on the important issue of securing the supply of quality pharmaceutical ingredients and products.”
The U.S. FDA speakers will field questions during the final plenary session of June 3. Brian Johnson, Sr. Director, Supply Chain Security, Pfizer, Inc., and chair of industry consortium Rx-360, will moderate the session.
Building on earlier PDA/FDA-cosponsored conferences and workshops on pharmaceutical supply chains, the 2014 event will provide a forum to further implementation of innovative approaches to protect the quality of the product to the patient, and to prevent illicit acts such as counterfeiting, diversion, and economic adulteration from threatening the safety of the drug supply.
For more information, including press registration, go to www.pda.org.